Immix Biopharma, Inc.
IMMX
$8.18
$0.172.12%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -10.69M | -7.59M | -6.62M | -4.54M | -4.81M |
| Total Depreciation and Amortization | 90.60K | 134.90K | 79.80K | 59.20K | 41.30K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 570.80K | 470.50K | 532.20K | 868.40K | 705.70K |
| Change in Net Operating Assets | -1.00M | 1.07M | 700.70K | 1.93M | 2.59M |
| Cash from Operations | -11.03M | -5.91M | -5.31M | -1.69M | -1.48M |
| Capital Expenditure | -165.10K | -372.50K | -127.60K | -67.70K | -507.20K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -6.48M | -- | -- | -- | -- |
| Cash from Investing | -6.65M | -372.50K | -127.60K | -67.70K | -507.20K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 95.64M | 10.77M | 1.11M | -- | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 29.80K | -166.80K | -- | -- | -- |
| Cash from Financing | 95.67M | 10.61M | 1.11M | -- | 0.00 |
| Foreign Exchange rate Adjustments | -11.70K | -20.60K | 44.10K | -8.00K | -25.10K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 77.98M | 4.31M | -4.28M | -1.76M | -2.01M |